Resorcylidene aminoguanidine improves the pathologically reduced fluidity of erythrocyte membranes in diabetes mellitus

Pharmazie. 2000 Sep;55(9):700-1.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anisotropy
  • Diabetes Mellitus, Type 1 / blood*
  • Erythrocyte Membrane / drug effects*
  • Erythrocyte Membrane / physiology
  • Guanidines / pharmacology*
  • Humans
  • In Vitro Techniques
  • Membrane Fluidity / drug effects*

Substances

  • Guanidines
  • resorcylidene aminoguanidine